Home medical devices belong to the consumer health sector. In recent years, the global market size has shown a growth trend, with the North American market benefiting from mature healthcare reimbursement systems, while the Asia-Pacific region holds vast potential. In China, driven by supportive national policies, the import substitution process for high-end home medical devices is accelerating.

Additionally, rising health management awareness among sub-healthy populations, professional rehabilitation groups, and the elderly has increased demand for various home medical devices, leading to continuous market expansion. The market is projected to exceed RMB 300 billion by 2026.

Currently, therapeutic home medical devices dominate the global market, while China’s home medical device market is primarily focused on monitoring products, such as blood pressure monitors and glucose meters, which have high penetration rates. Influenced by traditional Chinese medicine (TCM), products like cupping sets, gua sha boards, and acupuncture needles also occupy a portion of the Chinese market.

Chinese manufacturers mainly compete in the mid- to low-end segments, lacking competitiveness in the high-end market. However, as leading Chinese companies grow and accelerate exports, China’s overall competitiveness in the global home medical device market is expected to improve.

The industry is undergoing significant transformation, with core trends centered on online sales, product miniaturization, and smart technologies.

This report examines the current market landscape and emerging trends shaping China's medical device sector, focusing on key growth drivers, competitive dynamics,and future opportunities.

The Market Size and Development Potential of China's Home Medical Devices

Rapid Market Expansion

The aging population has driven demand for home medical devices, leading to rapid industry growth. According to BMD Medical’s IPO prospectus, China’s medical device market reached RMB 770.1 billion in 2020, with home medical devices accounting for RMB 239.5 billion (31%). By 2025, the total medical device market is projected to grow to RMB 1.2945 trillion, with home medical devices rising to RMB 463.8 billion (36% share), reflecting a compound annual growth rate (CAGR) of 14%—higher than the 11% CAGR for the broader medical device market and significantly surpassing the 7% CAGR for in-hospital medical imaging equipment. This positions home medical devices as a high-growth segment within the medical sector.

Regional Distribution

Common home medical devices include:

⭐Therapeutic devices:Far-infrared therapy instruments, magnetic therapy devices.

⭐Monitoring devices: Blood pressure monitors, glucose meters, digital thermometers, stethoscopes.

⭐Rehabilitation aids: Home oxygen concentrators, cervical/lumbar traction devices, orthotic equipment.

⭐Medical consumables: Cotton swabs, gauze, sterilized cotton balls.

⭐Topical products: Cooling patches, heat therapy pads.

Globally, therapeutic devices dominate the home medical device market, holding a 46.9% share, driven by rising prevalence of chronic respiratory diseases, increased healthcare spending, and demand for convenient medical services. In China, monitoring devices lead the market, with high penetration rates for blood pressure monitors and glucose meters. Additionally, TCM-influenced products like cupping sets, gua sha boards, and acupuncture needles occupy a notable share of the Chinese market.

Why Home Medical Devices Are a High-Growth Sector

Elevated Net Profit Margins

From 2019 to 2023, the net profit margin (TTM, aggregate method) for the home medical device sector increased from 14% to 23%. This steady improvement, supported by product scaling and new launches, positions the sector’s profitability at the top tier within the healthcare industry. In 2023, the sector’s net profit margin ranked highest among all subsectors under the Shenwan healthcare classification, maintaining a top-three position from 2019 to 2023. The strong "brand power" of home medical devices creates high barriers to entry, and continued product premiumization is expected to sustain profitability at industry-leading levels.

Fragmented Supply Side ≠ Low Barriers to Entry

While the home medical device market features diverse products and numerous manufacturers, leading listed companies leverage channel advantages and product diversification. However, a fragmented supply chain does not imply low barriers to entry. Technical challenges such as product certifications, stability requirements, and premiumization create significant barriers. Brand equity remains a critical competitive moat, enabling high profitability.

Premiumization Drives Gross Margins

From 2019 to 2023, the sector’s gross margin (aggregate method) rose from 45% to 53%. Key players like Andon Medical, Yuwell Medical, and Cofoe Medical saw margin improvements through continuous product upgrades. In 2023, the sector’s gross margin ranked second within the healthcare industry, maintaining a top-three position from 2020 to 2023.

Brand Power and Economies of Scale

Strong brand recognition accelerates product adoption and scale effects. Chinese revenue for home medical device companies shows a high correlation with online follower counts (R²=0.9789). Brand building—through time, product quality, portfolio completeness, and after-sales service—creates long-term competitive advantages.

Sustained Growth Drivers in the Home Medical Device Industry

Aging Population and Chronic Disease Demand

China’s population aged 65 and above is expected to reach 230 million by 2025, with 75% suffering from chronic diseases. This drives surging demand for long-term monitoring devices like glucose meters and oxygen concentrators. With 140 million diabetic patients and 270 million hypertensive patients, home monitoring devices have become essential.

Product Premiumization and Smart Technologies

From 2019 to 2023, the average adjusted net profit margin for home medical device companies surged from 2.9% to 18%, driven by:

⭐Scale effects from rapid product adoption.

⭐R&D investment growth: Average R&D spending increased from RMB 110 million to RMB 280 million, enabling innovation-led premiumization.

Policy Support and Healthcare Reforms

Since 2022, reforms to personal medical insurance accounts have expanded coverage to include glucose meters, blood pressure monitors, and thermometers in regions like Jiangsu, Shanghai, and Lanzhou. This policy shift is expected to accelerate market penetration as more regions adopt similar measures.

Top 4 Home Medical Devices Dominating the Chinese Market

Global manufacturers dominate the high-end home medical device market with first-mover, technological, and scale advantages. Chinese players, historically focused on mid- to low-end segments, are gradually enhancing competitiveness through exports and innovation:

BMC Medical:Innovative home ventilator manufacturer.

Patent leadership: Won multiple patent disputes against global leader ResMed.

Regulatory approvals:FDA and CE certifications; products reimbursed in the U.S., Germany, Italy, and Turkey.

Market share growth: Global share rose from 4.5% (2020) to 17.7% (2022).

Yuwell Medical: Leading Chinese home medical devices brand.

Market dominance: Highest e-commerce follower count and ROE among listed Chinese companies.

Product launches:Introduced 14-day calibration-free continuous glucose monitors (CGM) and produced AEDs in China in 2023.

Global expansion: Strengthened overseas recognition and distribution channels.

Sinocare: Glucose meter specialist.

Product leadership: Highest Chinese market share in traditional blood glucose monitors (BGM); launched CGM systems in 2023.

Proprietary technology: Third-generation direct electron transfer technology for CGMs.

Global certifications: EU MDR, UK, and Southeast Asian approvals for CGM products.

Cofoe Medical: Diversified home device provider.

Portfolio breadth: Covers health monitoring, rehabilitation aids, respiratory support, medical nursing, and TCM therapy.

R&D growth: Increased R&D spending from RMB 20 million (2019) to RMB 110 million (2023).

Global Home Medical Device Trends: Lessons from China’s Market

The global medical device market reached 612 billion in 2023. Home medical devices, accounting for 25% ($153 billion) of the total, are the fastest-growing segment (7.5% CAGR).By 2030, 14% of the global population will be over 65, fueling demand for chronic disease management and homecare solutions.China’s dominance in mid-tier devices like blood glucose meters (71% share) and portable ventilators mirrors broader demand patterns in emerging markets such as India and Brazil, where affordability and basic monitoring tools are prioritized. Meanwhile, developed markets like the U.S. and Europe focus on premium innovations, exemplified by AI-integrated devices (e.g., remote patient monitoring systems) and stringent compliance with FDA/CE standards.

Global Regional Market Dynamics

Developed Markets: Premiumization and Smart Technologies

North America (38% Market Share):

• The U.S. dominates the $18 billion remote patient monitoring (RPM) sector, with AI-powered tools like Butterfly Network’s handheld ultrasound gaining FDA breakthrough status.
• Rising demand for home dialysis devices (9% CAGR) reflects shifting care models.

Europe (30% Market Share):

• Germany and France lead in rehabilitation robotics (e.g., ReWalk exoskeletons), while the EU Green Deal pushes recyclable device R&D.
• Challenges: MDR compliance costs rose 30%, squeezing smaller players.

Emerging Markets: Accessibility and Localization

China (18% Market Share):

• The home medical device market grows at 14% CAGR, targeting $42 billion by 2026. Exports of glucose meters (Yuwell) and oxygen concentrators (BMC Medical) now account for 35% of output.

• Policy: 12 provinces now reimburse glucose meters under public insurance, boosting Chinese substitution to 70%.

India and Africa:

• India: The “Ayushman Bharat” initiative slashed glucometer prices to $12, raising rural adoption to 40%.
• Africa: Chinese-backed factories (e.g., Nigeria’s portable ventilator plants) cut costs, while solar-powered devices address energy gaps.

Other Key Regions

• Latin America: Tariff reductions under regional trade pacts lifted China-made blood pressure monitors to 45% market share in Brazil and Mexico.
• Middle East: UAE’s “Medical City” project attracts Medtronic and Siemens for localized imaging equipment production.

Key Global Trends Accelerated by China’s Growth:

Cost-Effective Scaling: Emerging economies are adopting China’s high-volume, low-margin model to expand healthcare access.

Smart Device Proliferation: IoT and AI adoption in Chinese products (e.g., Yuwell’s cloud-connected monitors) align with global telehealth investments, projected to grow at 18% CAGR through 2030.

Regulatory Hybridization: China’s push for international certifications (e.g., Sinocare’s EU MDR-approved CGMs) highlights a global shift toward harmonizing standards to ease cross-border trade.

Future Outlook

Emerging Markets: Southeast Asia and Africa will likely replicate China’s emphasis on scalable, mid-tier devices, driven by partnerships with Chinese OEMs.

High-Income Regions: Demand for interoperable, clinic-grade home mdeical devices (e.g., AI-driven diagnostics) will intensify, with Chinese brands like Andon competing on innovation rather than price.

Policy Synergies: China’s “Healthy Silk Road” initiative could bridge gaps in global supply chains, while climate regulations (e.g., EU CBAM) may reshape manufacturing hubs.

China is no longer just the “world’s factory” but a strategic disruptor in democratizing healthcare access worldwide.

Online Sales Dominance

Over 30% of health e-commerce users purchase home medical devices via platforms like Alibaba Health and Tmall Health. Online channels enhance market reach, transaction efficiency, and consumer experience.

Product Miniaturization

Compact designs (e.g., portable ventilators, mini glucose meters) cater to urban lifestyles with limited living space.

Smart Technology Integration

IoT, big data, and AI enable personalized health management. Examples include smart glucose meters that sync data to cloud platforms and telemedicine-enabled devices for real-time physician consultations.

FAQs

Q1: How to Choose Reliable Home Medical Devices?

Focus on certifications (CFDA/FDA), brand reputation, and after-sales support.With over a decade of expertise, Medasia connects you with factories that precisely meet your requirements, delivering premium products and services tailored to your needs.

Q2: What Are the Best-Selling Home Medical Devices?

Top sellers include blood glucose meters (71% market share), portable oxygen concentrators, and powered blood pressure monitors. Explore our product catalog for details.

The Company of Medasia

Medasia is dedicated to fostering global accessibility to healthcare by empowering individuals through self-care. Our ambition is to ensure that people worldwide have the means and knowledge to take control of their well-being.

Medasia, driven by innovation, specializes in self-tests for various medical conditions. We provide products that empower individuals to proactively manage their health conveniently and independently. Take the first step towards a healthier future with us.

Interested in learning more or purchasing home medical devices?

Contact us info@medasiagroup.com

Sources: WHO, Frost & Sullivan, BCG, Corporate Annual Reports,Wind, BMC Medical‘s IPO Prospectus, Zheshang Securities Research, Sinocare Annual Reports, Cofoe Medical Financial Reports.